Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

2018

Nakahara T, Petrov A, Tanimoto T, Chaudhry F, Narula N, Seshan SV, et al. Molecular Imaging of Apoptosis in Cancer Therapy-Related Cardiac Dysfunction Before LVEF Reduction. JACC Cardiovasc Imaging. 2018;11(8):1203-1205.
Morales A, Mathur-Wagh U, Tran A, Cui I, DeSimone RA, Jenkins SG, et al. Cavitary Pulmonary Nodules in an Immunocompromised Patient With Urothelial Carcinoma of the Bladder. Clin Infect Dis. 2018;67(10):1631-1634.
Castellino A, Chiappella A, LaPlant BR, Pederson LD, Gaidano G, Macon WR, et al. Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. Blood Cancer J. 2018;8(11):108.
Goyal A, Street J, Alperstein SA, Siddiqui MT. HPV test result monitoring of different Bethesda categories in gynaecologic cytology: A valuable quality assurance measure. Diagn Cytopathol. 2018;46(11):914-918.
Chedgy EC, Vandekerkhove G, Herberts C, Annala M, Donoghue AJ, Sigouros M, et al. Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma. J Pathol. 2018;246(2):244-253.
Moore MD, Postma E, Gray KD, Ullmann TM, Hurley JR, Goldsmith S, et al. Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma. World J Surg. 2018;42(2):343-349.
Nottegar A, Tabbo F, Luchini C, Brunelli M, Bria E, Veronese N, et al. Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology. Appl Immunohistochem Mol Morphol. 2018;26(6):383-387.
Hung PJ, Johnson B, Chen B-, Byrum AK, Bredemeyer AL, Yewdell WT, et al. MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. Mol Cell. 2018;71(2):332-342.e8.
Gordon JK, Martyanov V, Franks JM, Bernstein EJ, Szymonifka J, Magro C, et al. Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial. Arthritis Rheumatol. 2018;70(2):308-316.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700